Piramal Healthcare Gains After Unit Settles Patent Litigation

Piramal Healthcare Ltd. (PIHC) climbed in Mumbai trading after its unit Piramal Critical Care Inc. settled a patent litigation related to Baxter Healthcare Corp.’s Suprane or desflurane inhaled anesthetic agent.

The stock rose 1 percent to 364 rupees as of 9:17 a.m. local time.

To contact the editor responsible for this story: Suresh Seshadri at sseshadri1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.